Waverley Pharma Inc. (TSXV:WAVE)

Waverley Pharma Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.04	0.24	0.05	0.13	0.16
Cash & Short-Term Investments	0.04	0.24	0.05	0.13	0.16
Cash Growth	-80.95%	345.02%	-60.38%	-15.38%	-77.75%
Accounts Receivable	0.03	0.21	0.14	0.19	0.7
Inventory	0.31	0.26	0	0.06	0.33
Other Current Assets	0.04	0.02	0.22	0.24	0.26
Total Current Assets	0.42	0.73	0.42	0.63	1.45
Net Property, Plant & Equipment	0.22	0.26	-	-	-
Other Intangible Assets	0.33	0.4	-	-	1.76
Goodwill	0.21	0.22	-	-	-
Other Long-Term Assets	0.06	0.43	0.54	2.05	0.48
Total Assets	1.24	2.05	0.95	2.69	3.68
Accounts Payable	0.37	1.01	0.49	0.74	1.06
Short-Term Debt	3.22	2.81	1.6	0.7	0.26
Current Portion of Leases	0.05	0.04	-	-	-
Other Current Liabilities	0	-	-	0.16	0.57
Total Current Liabilities	3.64	3.86	2.09	1.6	1.89
Long-Term Leases	0.18	0.22	-	-	-
Total Long-Term Liabilities	0.18	0.22	-	-	-
Total Liabilities	4.08	4.08	2.09	1.6	1.89
Common Stock	7	7	7	7	7
Additional Paid-in Capital	1.33	1.33	1.33	1.33	1.33
Accumulated Other Comprehensive Income	-0.06	-0.02	-0.07	-0.07	-0.04
Retained Earnings	-10.84	-10.34	-9.4	-7.17	-6.51
Shareholders' Equity	-2.57	-2.03	-1.14	1.09	1.79
Total Liabilities & Equity	1.24	2.05	0.95	2.69	3.68
Total Debt	3.44	3.07	1.6	0.7	0.26
Net Cash (Debt)	-3.4	-2.83	-1.55	-0.57	-0.1
Net Cash Per Share	-0.06	-0.05	-0.03	-0.01	-0.00
Book Value	-2.57	-2.03	-1.14	1.09	1.79
Book Value Per Share	-0.05	-0.04	-0.02	0.02	0.03
Tangible Book Value	-3.11	-2.65	-1.14	1.09	0.03
Tangible Book Value Per Share	-0.06	-0.05	-0.02	0.02	0.00

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.